American Riviera
You are here:  Home  >  Central Coast Health Watch  >  Current Article

Amgen wins new FDA approval for cancer drug Xgeva

By   /   Friday, January 5th, 2018  /   Comments Off on Amgen wins new FDA approval for cancer drug Xgeva

    Print       Email
The largest international study of multiple myeloma, in which more than 1,700 patients participated, netted Amgen a new approval from the U.S. Food and Drug Administration. The Thousand Oaks biotech company announced Jan. 5 that its treatment Xgeva had gotten approval from regulators to treat multiple myeloma patients after showing that it effectively blocks proteins…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

CSUCI’s interim president named to permanent post

Read More →